PBLA logo

Panbela Therapeutics, Inc. (PBLA)

Profile

Full Name

Panbela Therapeutics, Inc.

Ticker

NASDAQ: PBLA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 3, 2017

Indexes

Not included

Website

https://www.panbela.com

Employees

7

Key Details

Price

$0.05(-66.67%)

Market cap

$242.74K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$316.52(+99.22% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.05
    PBLA price is $0.05

    30-Day Relative Volume

    1.46
    PBLA 30-day relative volume is 1.46

    Price Performance

    Price Most recent change

    -66.67%
    PBLA price was down -66.67% on Sep 8, 2025

    Price YTD change

    -86.84%
    PBLA price is down -86.84% since January 1st

    Price 1-year change

    -84.85%
    PBLA price is down -84.85% year-on-year

    Price 3-year change

    -100%
    PBLA price is down -100% over the past 3 years

    Price Range

    Price All-time high

    $1.08M
    PBLA price is currently -100.00% below its historical high of $1.08 million

    Price 3-year low

    $0.01
    PBLA price is currently +400.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $242.74K
    PBLA market capitalization is $242.74 thousand

    Market cap 3-year change

    -97.84%
    PBLA market capitalization is down -97.84% over the past 3 years

    Market cap All-time high

    $143.09M
    PBLA market capitalization is currently -99.83% below its historical high of $143.09 million

    Market cap sector rank

    2.69%
    PBLA market capitalization is higher than 2.69% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    PBLA shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +539322.22%
    PBLA shares outstanding is up +539322.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.93
    PBLA beta is -0.93

    200-day SMA

    $0.29
    PBLA price is currently -82.46% below its 200-day simple moving average

    50-day SMA

    $0.17
    PBLA price is currently -70.17% below its 50-day simple moving average

    RSI

    9.28
    PBLA 14-day relative strength index is 9.28

    Volume

    1.46
    PBLA 30-day relative volume is 1.46

    ATR

    $0.02
    PBLA average true range is $0.02

    10-day Historical Volatility

    332.82%
    PBLA 10-day historical volatility is 332.82%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    PBLA annual revenue is $0.00

    Revenue Analysts estimate

    -
    PBLA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    PBLA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    PBLA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$316.52
    PBLA annual earnings per share is -$316.52

    EPS Analysts estimate

    -
    PBLA annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +99.22%
    PBLA annual earnings per share is up +99.22% year-on-year

    EPS Sector rank

    1.85%
    PBLA annual earnings per share is higher than 1.85% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    PBLA annual gross profit is $0.00

    Gross margin

    -
    PBLA annual gross profit margin value is unknown

    Operating profit

    -$25.65M
    PBLA annual operating income is -$25.65 million

    Operating margin

    -
    PBLA annual operating profit margin value is unknown

    Net income

    -$25.26M
    PBLA annual net profit is -$25.26 million

    Net margin

    -
    PBLA annual net profit margin value is unknown

    Expenses

    Total expenses

    $25.26M
    PBLA annual total expenses is $25.26 million

    Operating expenses

    $25.65M
    PBLA annual total operating expenses is $25.65 million

    Cost of goods sold

    $0.00
    PBLA annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $5.03M
    PBLA annual SGA is $5.03 million

    Depreciation and amortization

    -
    PBLA annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    PBLA annual interest expense is $0.00

    Income tax

    -$186.00K
    PBLA annual income tax is -$186.00 thousand

    EBIT & EBITDA

    EBIT

    -$25.65M
    PBLA annual earnings before interest & taxes is -$25.65 million

    EBITDA

    -$25.65M
    PBLA annual EBITDA is -$25.65 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $11.80M
    PBLA annual total assets is $11.80 million

    Non current assets

    $8.74M
    PBLA annual long term assets is $8.74 million

    Current assets

    $3.06M
    PBLA annual total current assets is $3.06 million

    Cash and cash equivalents

    $2.58M
    PBLA annual cash & cash equivalents is $2.58 million

    Accounts receivable

    -
    PBLA annual accounts receivable value is unknown

    Inventory

    $0.00
    PBLA annual inventory is $0.00

    Liabilities

    Total liabilities

    $16.51M
    PBLA annual total liabilities is $16.51 million

    Long term liabilities

    $4.19M
    PBLA annual total long term liabilities is $4.19 million

    Current liabilities

    $12.32M
    PBLA annual total current liabilities is $12.32 million

    Accounts payable

    $9.94M
    PBLA annual accounts payable is $9.94 million

    Debt

    Total debt

    $5.19M
    PBLA annual total debt is $5.19 million

    Total debt 1-year change

    -24.11%
    PBLA annual total debt is down -24.11% year-on-year

    Long term debt

    $4.19M
    PBLA annual long term debt is $4.19 million

    Short term debt

    $1.00M
    PBLA annual short term debt is $1.00 million

    Equity & Capital

    Shareholders equity

    -$4.71M
    PBLA annual stockholders equity is -$4.71 million

    Book value

    -$4.71M
    PBLA annual book value is -$4.71 million

    Retained earnings

    -$125.50M
    PBLA annual retained earnings is -$125.50 million

    Working capital

    -$9.26M
    PBLA annual working capital is -$9.26 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$25.25M
    PBLA annual cash flow from operations is -$25.25 million

    Cash from operations 1-year change

    -65.29%
    PBLA annual cash flow from operations is down -65.29% year-on-year

    Cash from investing

    $400.00K
    PBLA annual cash flow from investing activities is $400.00 thousand

    Cash from investing 1-year change

    +160.98%
    PBLA annual cash flow from investing activities is up +160.98% year-on-year

    Cash from financing

    $26.14M
    PBLA annual cash flow from financing activities is $26.14 million

    Cash from financing 1-year change

    +388.27%
    PBLA annual cash flow from financing activities is up +388.27% year-on-year

    CAPEX

    CAPEX

    $0.00
    PBLA annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    PBLA annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$25.25M
    PBLA annual free cash flow is -$25.25 million

    Free cash flow 1-year change

    -65.29%
    PBLA annual free cash flow is down -65.29% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    PBLA annual gross profit margin value is unknown

    Operating margin

    -
    PBLA annual operating profit margin value is unknown

    Net margin

    -
    PBLA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -301.11%
    PBLA annual return on assets is -301.11%

    ROE

    536.37%
    PBLA annual return on equity is 536.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PBLA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PBLA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.01
    PBLA price to book ratio is -0.01

    PB ratio Sector rank

    15.57%
    PBLA price to book ratio is higher than 15.57% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    PBLA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    PBLA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $6.49M
    PBLA enterprise value is $6.49 million

    Enterprise value Sector rank

    19.68%
    PBLA enterprise value is higher than 19.68% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.22
    PBLA EV/EBITDA is -0.22

    EV/EBITDA Sector rank

    59.36%
    PBLA EV/EBITDA is higher than 59.36% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.25
    PBLA annual current ratio is 0.25

    Quick ratio

    0.25
    PBLA annual quick ratio is 0.25

    Leverage

    Debt to equity

    -1.10
    PBLA annual debt to equity ratio is -1.10

    Interest coverage ratio

    -
    PBLA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    PBLA piotroski f-score value is unknown

    Altman Z-Score

    -22.99
    PBLA altman z-score is -22.99

    Analyst ratings

    Recent major analysts updates

    Aug 15, 24 HC Wainwright & Co.
    Neutral
    Jun 24, 24 HC Wainwright & Co.
    Neutral
    May 16, 24 HC Wainwright & Co.
    Neutral
    Apr 2, 24 HC Wainwright & Co.
    Buy
    Mar 27, 24 Roth MKM
    Buy
    Feb 5, 24 Roth MKM
    Buy
    Dec 18, 23 Roth MKM
    Buy
    Aug 11, 23 HC Wainwright & Co.
    Buy
    Jul 24, 23 HC Wainwright & Co.
    Buy
    Jul 10, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with PBLA included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Panbela Therapeutics, Inc.?
    • Does Panbela Therapeutics, Inc. pay dividends?
    • What sector is Panbela Therapeutics, Inc. in?
    • What industry is Panbela Therapeutics, Inc. in?
    • What country is Panbela Therapeutics, Inc. based in?
    • When did Panbela Therapeutics, Inc. go public?
    • Is Panbela Therapeutics, Inc. in the S&P 500?
    • Is Panbela Therapeutics, Inc. in the NASDAQ 100?
    • Is Panbela Therapeutics, Inc. in the Dow Jones?
    • When was Panbela Therapeutics, Inc.'s last earnings report?
    • When does Panbela Therapeutics, Inc. report earnings?

    What is the ticker symbol for Panbela Therapeutics, Inc.?

    The ticker symbol for Panbela Therapeutics, Inc. is NASDAQ:PBLA

    Does Panbela Therapeutics, Inc. pay dividends?

    No, Panbela Therapeutics, Inc. does not pay dividends

    What sector is Panbela Therapeutics, Inc. in?

    Panbela Therapeutics, Inc. is in the Healthcare sector

    What industry is Panbela Therapeutics, Inc. in?

    Panbela Therapeutics, Inc. is in the Biotechnology industry

    What country is Panbela Therapeutics, Inc. based in?

    Panbela Therapeutics, Inc. is headquartered in United States

    When did Panbela Therapeutics, Inc. go public?

    Panbela Therapeutics, Inc.'s initial public offering (IPO) was on January 3, 2017

    Is Panbela Therapeutics, Inc. in the S&P 500?

    No, Panbela Therapeutics, Inc. is not included in the S&P 500 index

    Is Panbela Therapeutics, Inc. in the NASDAQ 100?

    No, Panbela Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Panbela Therapeutics, Inc. in the Dow Jones?

    No, Panbela Therapeutics, Inc. is not included in the Dow Jones index

    When was Panbela Therapeutics, Inc.'s last earnings report?

    Panbela Therapeutics, Inc.'s most recent earnings report was on July 23, 2025

    When does Panbela Therapeutics, Inc. report earnings?

    The date for Panbela Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page